Supplementary Table 2. Adjusted mean differences (95% confidence intervals) of lipid and clinical parameters according to serum Lp(a) categories at baseline＊ .
| Parameter | N† | Lp(a) category (mg/dL) | Trend P | |||
|---|---|---|---|---|---|---|
| ＜20 (n = 192) | 20–29 (n = 67) | 30–39 (n = 52) | 40+ (n = 88) | |||
| LDL cholesterol (mg/dL) | 391 | 0.00 (referent) | 5.59 (−6.19;17.4) | 1.39 (−11.5; 14.3) | 4.70 (−6.12; 15.5) | 0.43 |
| HDL cholesterol (mg/dL) | 399 | 0.00 (referent) | 3.62 (−0.95; 8.19) | −0.24 (−5.30; 4.83) | −4.24 (−8.46; −0.01) | 0.07 |
| ln (Triglycerides [mg/dL]) | 399 | 0.00 (referent) | −0.03 (−0.17; 0.12) | −0.19 (−0.35; −0.03) | −0.14 (−0.28; −0.01) | 0.01 |
| Apolipoprotein AI (mg/dL) | 352 | 0.00 (referent) | 2.92 (−6.31; 12.2) | −4.88 (−15.3; 5.56) | −9.81 (−18.5; −1.15) | 0.02 |
| Apolipoprotein B (mg/dL) | 353 | 0.00 (referent) | 3.19 (−4.81; 11.2) | 3.54 (−5.57; 12.6) | 7.92 (0.36; 15.5) | 0.04 |
| Apolipoprotein E(mg/dL) | 343 | 0.00 (referent) | 0.20 (−0.22; 0.61) | 0.25 (−0.22; 0.73) | 0.36 (−0.03; 0.75) | 0.06 |
| ln (RLPC [mg/dL]) | 312 | 0.00 (referent) | −0.01 (−0.21; 0.19) | −0.04 (−0.28; 0.20) | −0.09 (−0.28; 0.09) | 0.33 |
| Rf | 149 | 0.00 (referent) | −0.02 (−0.04; −0.00) | −0.00 (--0.03; 0.02) | 0.01 (−0.01; 0.03) | 0.50 |
| Maximal IMT (mm) | 359 | 0.00 (referent) | 0.10 (−0.11; 0.31) | −0.08 (−0.31; 0.15) | 0.10 (−0.10; 0.30) | 0.51 |
| Mean IMT (mm) | 324 | 0.00 (referent) | 0.00 (−0.09; 0.09) | 0.00 (−0.10; 0.10) | 0.03 (−0.05; 0.11) | 0.47 |
| Achilles tendon thickness (mm) | 347 | 0.00 (referent) | 0.83 (−0.39: 2.06) | −0.65 (−2.03; 0.73) | 0.45 (−0.66; 1.56) | 0.70 |
＊Based on multiple regression analyses including age, familial coronary artery disease, and indicator variables for Lp(a) category in the model.
†Numbers of patients were not uniform due to missing information.